Spring Break
Protein interaction causes brain tumors
Issue date: 3/13/08
This region contains the other tumor suppressor, known as Hypermethyated In Cancer 1, or Hic1, on which the Hopkins team decided to focus its attention.
Hic1 is also a tumor suppressor. It has been shown that in medulloblastoma cancer cells, there is methylation of the gene, which encodes Hic1.
Methylation is a way for cells to silence genes that it does not want to express proteins. The problem with this is that cells can exploit this mechanism and use it to become cancerous. Since the gene for Hic1 is methylated, the Hic1 protein is not expressed and cannot properly suppress the cell from becoming cancerous.
When the researchers combined mutations of the Ptch protein and the Hic1 protein in a mouse, there was a higher level of medulloblastoma formation. From here, they wanted to know if there was an interaction in the pathway between Ptch, which can repress the Hedgehog pathway, and the Hic1 protein.
Using gene expression and other techniques, the researchers located a target of Hic1, a protein known as Atoh1. When Hic1 interacts with Atoh1, the Atoh1 protein is inactivated and cannot help to form medulloblastoma. However, it has been shown that in medulloblastoma, Atoh1 is highly expressed, implicating its role in tumorigenesis.
Using molecular biology techniques, the researchers were also able to show that Hic1 acts downstream, meaning it acts after other proteins in that pathway, in the Hedgehog pathway, showing a connection between Ptch1, which represses the Hedgehog pathway, and Hic1, which acts downstream in the Hedgehog pathway to stop the activation of Atoh1.
From all of this data the researchers were able to demonstrate that epigenetic regulation of the gene which encodes Hic1 regulates the formation of medulloblastoma.
Epigenetics is the branch of genetics in which the genes stay the same, but modifications can occur on those genes which regulate how they are used.
Thus, in normal granule precursor cells, the Hic1 gene is not methylated and the Hic1 protein can then work properly to suppress the formation of cancer by blocking the action of Atoh1. Furthermore, when the Hic1 gene is methylated, it cannot do its job properly and formation of medulloblastoma occurs by overexpression of Atoh1.
With this specific information about the formation of medulloblastoma, therapeutics directly targeting this pathway are underway.
Currently there are treatments for other diseases which de-methylate genes and allow the gene products to function properly. There is hope that these same therapeutics will one day help to cure this aggressive childhood cancer.
Hic1 is also a tumor suppressor. It has been shown that in medulloblastoma cancer cells, there is methylation of the gene, which encodes Hic1.
Methylation is a way for cells to silence genes that it does not want to express proteins. The problem with this is that cells can exploit this mechanism and use it to become cancerous. Since the gene for Hic1 is methylated, the Hic1 protein is not expressed and cannot properly suppress the cell from becoming cancerous.
When the researchers combined mutations of the Ptch protein and the Hic1 protein in a mouse, there was a higher level of medulloblastoma formation. From here, they wanted to know if there was an interaction in the pathway between Ptch, which can repress the Hedgehog pathway, and the Hic1 protein.
Using gene expression and other techniques, the researchers located a target of Hic1, a protein known as Atoh1. When Hic1 interacts with Atoh1, the Atoh1 protein is inactivated and cannot help to form medulloblastoma. However, it has been shown that in medulloblastoma, Atoh1 is highly expressed, implicating its role in tumorigenesis.
Using molecular biology techniques, the researchers were also able to show that Hic1 acts downstream, meaning it acts after other proteins in that pathway, in the Hedgehog pathway, showing a connection between Ptch1, which represses the Hedgehog pathway, and Hic1, which acts downstream in the Hedgehog pathway to stop the activation of Atoh1.
From all of this data the researchers were able to demonstrate that epigenetic regulation of the gene which encodes Hic1 regulates the formation of medulloblastoma.
Epigenetics is the branch of genetics in which the genes stay the same, but modifications can occur on those genes which regulate how they are used.
Thus, in normal granule precursor cells, the Hic1 gene is not methylated and the Hic1 protein can then work properly to suppress the formation of cancer by blocking the action of Atoh1. Furthermore, when the Hic1 gene is methylated, it cannot do its job properly and formation of medulloblastoma occurs by overexpression of Atoh1.
With this specific information about the formation of medulloblastoma, therapeutics directly targeting this pathway are underway.
Currently there are treatments for other diseases which de-methylate genes and allow the gene products to function properly. There is hope that these same therapeutics will one day help to cure this aggressive childhood cancer.
Be the first to comment on this story